In March 2015 significant progress was achieved through a two day workshop organized by the National Institute of Health (NIH) led by the National Human Genome Research Institute (NHGRI) I in collaboration with the Food & Drug Administration (FDA). This meeting brought together 30 established SJS/TEN researchers to set priorities for the field.
A one day program March 2, 2017, aims to bring together a multidisciplinary group of individuals who are passionate about furthering the science and clinical care of SJS/TEN to network, brainstorm and mentor early investigators in the field. We are reaching out to a broad array of clinicians and scientists including dermatologists, ophthamologists, clinical pharmacologists, epidemiologists, surgeons, gynecologists, regulatory scientists, informaticians, immunologists, geneticists, skin biologists and basic scientists all of whom have much to contribute to this field. We will aim to have a presence of patients and SJS/TEN foundation representatives to keep this “real”.
Key goals will be to:
Key topics of interest will address:
This meeting will aim to attract an international audience as well as those attending the American Academy of Dermatology Meeting. A variety of presentation formats will be used to encourage interaction and will include:
*travel scholarships will be awarded for trainees presenting posters at this meeting.